Successful treatment of Kasabach-Merritt syndrome with pentoxifylline
- 1 November 1991
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 25 (5) , 854-855
- https://doi.org/10.1016/s0190-9622(08)80985-1
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes.Molecular Pharmacology, 2025
- Reduced thrombus formation in vivo after administration of pentoxifylline (TrentalR)Thrombosis Research, 1989
- White blood cells as mediators of hyperviscosity-induced tissue damage in neutrophilic vascular reactions: Therapy with pentoxifyllineJournal of the American Academy of Dermatology, 1989
- Pentoxifylline Therapy in Dermatology: A Review of Localized Hyperviscosity and Its Effects on the SkinDermatologic Clinics, 1988
- Kasabach-Merritt Syndrome: Therapeutic ConsiderationsPediatrics, 1987
- Intratumoral consumption of indium-111 labeled platelets in a patient with hemangiomatosis and intravascular coagulation (Kasabach-merritt syndrome)Cancer, 1983